Peking University Health Science Center Hospital赞助的临床试验
总计5953个结果
-
Peking University Cancer Hospital & Institute尚未招聘大肠癌 | 射频消融 | 肝转移 | KRAS基因 | 安全边际
-
Peking University Cancer Hospital & Institute招聘中
-
Peking University Cancer Hospital & Institute招聘中
-
Peking University Cancer Hospital & Institute完全的
-
Peking University Cancer Hospital & Institute未知
-
Peking University Cancer Hospital & Institute未知
-
Peking University Cancer Hospital & Institute未知
-
Peking University Cancer Hospital & Institute未知
-
Peking University Cancer Hospital & Institute未知
-
Peking University Cancer Hospital & Institute未知
-
Peking University Cancer Hospital & Institute完全的乳腺肿瘤 | 药物治疗 | 多态性,单核苷酸中国
-
Peking University Cancer Hospital & Institute完全的
-
Peking University Cancer Hospital & Institute完全的
-
Peking University Cancer Hospital & Institute未知
-
Peking University Cancer Hospital & Institute招聘中
-
Peking University Cancer Hospital & Institute招聘中
-
Peking University Cancer Hospital & Institute尚未招聘
-
Peking University Cancer Hospital & Institute招聘中
-
Peking University Cancer Hospital & Institute招聘中HER2阳性转移性乳腺癌 | 以前接受过曲妥珠单抗治疗 | 曲妥珠单抗联合帕妥珠单抗和化疗中国
-
Peking University Cancer Hospital & Institute招聘中
-
Peking University Cancer Hospital & Institute尚未招聘
-
Peking University Cancer Hospital & Institute完全的